Global Research

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (only available in desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Big Tech’s Effort to Silence Truth-tellers: Global Research Online Referral Campaign

***

In a shocking report (Morens et al., 2023), Dr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases (NIAID), has. This statement marks a 180-degree turn away from previous statements and public health strategies that have heavily relied on mRNA technology to curb the spread of diseases like COVID-19.

“RETHINKING” After Attempting to Force-Vaccinate the Entire Population of the Planet

In January 2023, Fauci, and two colleagues, outlined concerns rooted in the interplay between respiratory viruses and the human immune system. Unlike systemic infections, they claim, respiratory viruses primarily replicate in the mucosal linings of the airways, posing unique challenges for vaccine-induced immunity. This, of course, is not true; the virus replicates in any cell with an ACE2 receptor, and the highest density of virus detected in the lining of the gut. But we’ll move on from Fauci’s inability to grasp the full scientific literature.

Here are the key arguments underpinning Fauci et al.’s reversed position:

1. Mucosal vs. Systemic Immunity: mRNA vaccines are designed to elicit systemic immune responses, primarily through the generation of neutralizing antibodies. However, respiratory viruses require a robust mucosal immune response for effective neutralization and clearance. Fauci and colleagues argue that mRNA vaccines, in their current form, do not adequately stimulate mucosal immunity, potentially limiting their effectiveness against respiratory pathogens.
2. Durability of Protection: Another concern they point to involves the duration of protection offered by mRNA vaccines. Respiratory viruses, including influenza and coronaviruses, exhibit high mutation rates, leading to the emergence of new variants. The implication is that mRNA vaccines may not provide long-lasting immunity against these ever-evolving threats, requiring frequent updates and booster shots. (*SMH*).
3. Immune Imprinting: The phenomenon of “original antigenic sin” or immune imprinting is also highlighted as a potential issue. This concept suggests that exposure to a specific viral strain via vaccination could bias the immune system’s response to future infections, making it less effective against different strains. While mRNA vaccines can be quickly updated, repeated vaccinations might reinforce this imprinting, potentially complicating responses to new variants.

Pardon me while I duct-tape my head to keep it from exploding.

If Not mRNA, Then What?

Discussion brought forth by Dr. Fauci’s reversed position naturally concludes that ongoing research and development in vaccine technology is the answer.

Fauci et al. go on to discuss the future of vaccine strategies, emphasizing the importance of developing vaccines that elicit broad, durable, and mucosal immunity. Odd they did not cite my articles from 2020 and every other reasonable scientistic who saw that spike-only vaccination would yield temporary, shallow misfocused immunity.

Fauci et al. call for exploring novel adjuvants, delivery systems, and vaccine platforms that can overcome the limitations of current mRNA vaccines.

Things Fauci Said 

Fauci in January 2023 published that mRNA vaccines have failed against COVID-19. Here are some key quotes from the article that others can use to truly understand how anti-mRNA Fauci and his colleagues are:

1. On the Challenge of Mucosal Immunity: “Durably protective vaccines against non-systemic mucosal respiratory viruses with high mortality rates have thus far eluded vaccine development efforts.” This statement underscores the difficulty in creating vaccines that offer long-term protection against viruses that primarily infect the mucosal surfaces of the respiratory tract. Of course, we knew this before 2020, and it’s true. But it’s also a lie within a lie – given that the vaccinated have a higher risk of re-infection, and the evidence of immune impairment, and ADE after Delta, don’t take Fauci’s first statement as forthright.
2. On the Rapid Replication and Transmission of Respiratory Viruses: “In this review, we examine challenges that have impeded development of effective mucosal respiratory vaccines, emphasizing that all of these viruses replicate extremely rapidly in the surface epithelium and are quickly transmitted to other hosts, within a narrow window of time.” This highlights the challenge of developing vaccines that can effectively interrupt the transmission of respiratory viruses, which replicate and spread quickly. This was true of these viruses before mRNA vaccines came along, and there was ample evidence from studies of this technology in mice and rats that the immunity was not durable. But it’s also a lie within a lie – the mucosal lining is not the only site of infection; the GI tract also suffers, especially in the earlier variants.
3. On the Limitations of Current Vaccines: “The limitations of influenza and SARS-CoV-2 vaccines remind us that candidate vaccines for most other respiratory viruses have to date been insufficiently protective for consideration of licensure.” This quote points out the current limitations in vaccine efficacy against respiratory viruses, including those using mRNA technology. “VACCINES HAVE FAILED AGAINST REPIRATORY VIRUSES.” Pardon me while I pick up my jaw from the floor.
4. On the Need for Mucosal Immunity Stimulation: “One intriguing approach to pursue, as noted above, would be making vaccines that stimulate innate immunity which might be ideally suited to ‘hit and run’ infections by mucosal respiratory viruses, which characteristically infect, spread locally, and are transmitted to others before significant adaptive immune responses can be mobilized.” What, wait… Fauci knows about innate immunity? Next, he’ll conclude that many if not most people in the population didn’t need the vaccine, right??? But hold on here, this is the crux – he’s saying that he thinks that an effective vaccine strategy against respiratory viruses may need to focus more on stimulating mucosal and innate immunity rather than solely inducing systemic immune responses. Think about that for a minute. Rather than inject and bypass mucosal immunity… where have we heard this before?
5. On Suboptimal Pulmonary Immunity: “Current influenza vaccines are suboptimal at both preventing infection and eliciting pulmonary immunity.” Although this is specifically about influenza vaccines, it reflects a broader challenge in eliciting effective pulmonary immunity against respiratory viruses. Yet there the influenza vaccine program sits… ineffective as ever.

According to Fauci, vaccines that focus on systemic immunity do not fully address the unique requirements for combating respiratory viruses.

One question – where were these concerns prior to 2020? Why did policy not reflect this reality?

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Featured image is from Children’s Health Defense

Price: $11.50 FREE COPY! Click here (docsend) and download.

We encourage you to support the eBook project by making a donation through Global Research’s DonorBox “Worldwide Corona Crisis” Campaign Page.